Drug Information

Drug General Information
Drug ID
D0U9LT
Former ID
DIB016819
Drug Name
Y-39983
Synonyms
RKI-983; SNJ-1656; ROCK inhibitors, Mitsubishi Tanabe Pharma/Senju/Novartis; Rho-associated protein kinase inhibitors, Mitsubishi Tanabe Pharma/Senju/Novartis
Drug Type
Small molecular drug
Indication Glaucoma [ICD9: 365; ICD10:H40-H42] Phase 1/2 [522584]
Company
Mitsubishi Pharma Corp
Structure
Download
2D MOL

3D MOL
Formula
C16H18Cl2N4O
Canonical SMILES
c1c(ccc(c1)C(=O)Nc1ccnc2c1cc[nH]2)[C@@H](C)N.Cl
PubChem Compound ID
20601328
Target and Pathway
Target(s) Rho associated protein kinase Target Info Modulator
References
Ref 522584ClinicalTrials.gov (NCT00846989) Efficacy, Tolerability and Safety of RKI983 (0.05% & 0.10%) vs Xalatan in Patients With POAG or Ocular Hypertension. U.S. National Institutes of Health.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.